Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $34.5000 (0%) ($32.5000 - $36.1000) on Wed. Oct. 19, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.83% (three month average) | RSI | 61 | Latest Price | $34.5000(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.915% in a week (0% probabilities). TLT(-6%) IPO(-6%) VIXM(-5%) GLD(-5%) GDX(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.915% (StdDev 3.83%) | Hourly BBV | 0 () | Intraday Trend | 6.2% | | | |
|
5 Day Moving Average | $33.92(1.71%) | 10 Day Moving Average | $33.99(1.5%) | 20 Day Moving Average | $33.68(2.43%) | To recent high | -17.8% | To recent low | 9.2% | Market Cap | $680m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |